Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Writing letters to physicians who prescribe higher than average amount of a prescription drug has helped cut back, according to new research published in JAMA Psychiatry.
Researchers at the University of Utah Health have developed high-tech tools to uncover the genetic cause of early infantile epileptic encephalopathy (EIEE), according to a press release.
The Association of Black Cardiologists (ABC) announced the issuance of Prior Authorization (PA) Resource Kits designed specifically for cardiologists who work with underserved minority patients.
MIT researchers are using an artificial intelligence (AI) model that would help determine the correct drug dosage and, in turn, reduce debilitating side effects for brain cancer patients.
In another sign that Amazon is ramping up its entry into healthcare, the e-commerce giant is dipping its toes into primary care with a new offering for its Seattle-based employees.
HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.
Philips is recalling the software associated with its Mobile Cardiac Outpatient Telemetry devices after certain high-risk ECG events were never routed to trained cardiology technicians as intended. The issue, which lasted for two years, has been linked to more than 100 injuries.
Heart Rhythm Society President Kenneth A. Ellenbogen, MD, detailed a new advocacy group focused on improving EP reimbursements, patient care and access. “If you’re not at the table, you’re on the menu," he said.
